Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Proxi Biotech Logo
Proxi Biotech Growth Score
89
CB Rank
126572
Heat Score
80
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.
Founded
obfuscation
PrivateConvertible Note Copenhagen, Hovedstaden, Denmark1-10 www.proxibiotech.com/
Biotechnology
Health Care
Medical
Medical Device
Overview

Proxi Biotech
Total Funding
obfuscation
Growth Score
89
Heat Score
80

Total Funding
obfuscation
obfuscation
Convertible Note raised
obfuscation
Growth Score89
-1 pts
in past quarter
Heat Score 80
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Proxi Biotech

CB Rank
126572
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.
Founded
obfuscation
PrivateConvertible Note Copenhagen, Hovedstaden, Denmark1-10 www.proxibiotech.com/
Biotechnology
Health Care
Medical
Medical Device

Funding Rounds

Convertible Note
OBF
in
obfuscation
Convertible Note
OBF
in
obfuscation

Details

Legal Name Proxi Biotech ApS
Operating Status Active
Company Type For Profit
About the Company
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections. Its BACTOVAC platform technology detoxifies bacterial toxins and kills multi-drug-resistant bacteria. It was founded in 2017 and is headquartered in Copenhagen, Denmark.
Phone Number +45 2255 2202
Contact Email rj@proxibiotech.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

BACTOVAC Technology Platform
A proprietary toxoid-based active immunotherapy platform designed to develop vaccines targeting multi-drug-resistant bacterial infections.
Vaccine Candidate for Recurrent Clostridium difficile Infection
A vaccine developed using the BACTOVAC platform to prevent recurrent infections caused by Clostridium difficile bacteria.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note
obfuscation
Convertible Note - Proxi Biotech Logo
Convertible Note - Proxi Biotech
1
obfuscation
BioInnovation Institute Venture LabConvertible Note

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News
Technology
View Tech Report

IT Spend

$115.4KThis year, Proxi Biotech is projected to spend $115.4K on IT, according to Aberdeen.

Active Website Tech Count

4Proxi Biotech is actively using 4 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Pound Sterling.

Total IP

1Proxi Biotech has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Proxi Biotech's headquarters? Proxi Biotech is located in Copenhagen, Hovedstaden, Denmark.Who invested in Proxi Biotech? Proxi Biotech has 2 investors including BioInnovation Institute Venture Lab and  BioInnovation Institute.When was the last funding round for Proxi Biotech? Proxi Biotech closed its last funding round on
obfuscation
from a Convertible Note round.Who are Proxi Biotech's competitors? Alternatives and possible competitors to Proxi Biotech may include Pfizer, Sanofi, and  Idorsia.How much funding has Proxi Biotech raised to date? Proxi Biotech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|